NCT06053086View on ClinicalTrials.gov

SAHARA-04 : Adaptive Radiotherapy in Hypersensitive Patients and High Locoregional Risk Breast Cancer With ETHOS Technology

NANot yet recruitingINTERVENTIONAL
Enrollment

500

Participants

Timeline

Start Date

March 6, 2025

Primary Completion Date

March 31, 2029

Study Completion Date

April 30, 2029

Conditions
Breast Cancer
Interventions
RADIATION

Treatment ETHOS radiotherapy

• Cohort A: Adaptive RT: PTV = CTV + 2 mm (except for IMC with 5mm), excluding 5mm beneath the skin

RADIATION

Conventional IMRT

• Cohort B: IMRT: PTV = CTV + 7mm, excluding 5mm beneath the skin

Trial Locations (1)

34298

Centre Regional de Lutte Contre le Cancer - Centre Val d'Aurelle, Montpellier

All Listed Sponsors
lead

Institut du Cancer de Montpellier - Val d'Aurelle

OTHER